Dafalgan DOLO, Tabletten

7680475040027 CH-47504 Tabletten

Associated product:

DAFALGAN Dolo cpr 500 mg 16 pce
Dafalgan DOLO, Tabletten
Dafalgan DOLO, Tabletten
Dafalgan DOLO, Tabletten
1 / 3
google

Article details

Package size
16
Selling units
16
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
08/05/2025
Patient information leaflet
Français
08/05/2025
Patient information leaflet
Italien
08/05/2025
Summary of Product Characteristics
Allemand
08/05/2025
Summary of Product Characteristics
Français
08/05/2025
Summary of Product Characteristics
Italien
08/05/2025

Detailed composition

Substance Quantity Type Category
(N/A)
500.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

UPSA Switzerland AG

6300 Zug

Authorization information

Swissmedic authorization number
47504
Drug name
Dafalgan DOLO, Tabletten
Galenic form
TAB
ATC Code
N02BE01
Authorization status
Z
Dispensing category
D
First authorization
03/12/1986
Authorization expiration date
31/12/9999
IT Number
01.01.1.
Domain
Human medicine
Field of application
Analgetikum, Antipyretikum

Package details

Description (FR)
DAFALGAN Dolo cpr 500 mg 16 pce
Description (DE)
DAFALGAN Dolo Tabl 500 mg 16 Stk
Market launch
03/12/1986
Narcotic (BTM)
No

Other package sizes (4)

None
None None
GTIN: None
Not in V1
None
20 TABL
GTIN: None
Not in V1
DAFALGAN cpr 500 mg 16 pce
None None
GTIN: 7680475040157
Not in V1
DAFALGAN cpr 500 mg 100 pce
None None
GTIN: 7680475040232
Not in V1